Zoetis Inc operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zoetis Inc with three other
companies in this sector in the United States:
Regeneron Pharmaceuticals Incorporated
sales of $4.86 billion
of which 100%
was Research & Development),
Endo International PLC
of which 64%
was Generics), and
Eisai Company Limited
of which 49%
was Pharmaceutical Business -Japan).
During the year ended December of 2016, sales at
Zoetis Inc were $4.89 billion.
increase of 2.6%
versus 2015, when the company's sales were $4.77 billion.
Sales of International saw an increase
0.2% in 2016, from
$2.39 billion to $2.39 billion.